Recombinant Plasminogen Activator of the Sandworm (
E. coli
MBP
TEV
plasminogen activator
thrombolytic drug
Journal
Bioengineering (Basel, Switzerland)
ISSN: 2306-5354
Titre abrégé: Bioengineering (Basel)
Pays: Switzerland
ID NLM: 101676056
Informations de publication
Date de publication:
15 Oct 2024
15 Oct 2024
Historique:
received:
11
09
2024
revised:
11
10
2024
accepted:
14
10
2024
medline:
25
10
2024
pubmed:
25
10
2024
entrez:
25
10
2024
Statut:
epublish
Résumé
As an essential thrombolytic agent, the tissue plasminogen activator receives increasing attention due to its longer half-life, lower immunogenicity, and easier administration, which are superior to other thrombolytic agents. In this study, the isolated and purified plasminogen activator from the sandworm (
Identifiants
pubmed: 39451405
pii: bioengineering11101030
doi: 10.3390/bioengineering11101030
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Shanghai Frontiers Research Center of the Hadal Biosphere
ID : NA
Organisme : National Natural Science Foundation of China
ID : 82173731
Organisme : Research Fund for International Young Scientists
ID : 81750110548
Organisme : CSPFTZ Lingang Special Area Marine Biomedical Innovation Platform
ID : NA